Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity

समान संसाधन

• Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity
  द्वारा: Corbin, Amie S., और अन्य
  प्रकाशित: (2010)
• Absence of SKP2 expression attenuates BCR-ABL–induced myeloproliferative disease
  द्वारा: Agarwal, Anupriya, और अन्य
  प्रकाशित: (2008)
• BCR-ABL SH3-SH2 domain mutations in chronic myeloid leukemia patients on imatinib
  द्वारा: Sherbenou, Daniel W., और अन्य
  प्रकाशित: (2010)
• Mutant BCR-ABL clones in chronic myeloid leukemia
  द्वारा: Mathisen, Michael S., और अन्य
  प्रकाशित: (2011)
• A BCR-ABL mutant lacking direct binding sites for the GRB2, CBL and CRKL adapter proteins fails to induce leukemia in mice.
  द्वारा: Kara J Johnson, और अन्य
  प्रकाशित: (2009-10-01)